文献速递血栓与止血

荷兰血友病患者2001-2018年死亡率、预期寿命及死因分析

Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018.
PubMed 文献 · J Thromb Haemost · 2020-12-18

该观察性队列研究随访了2001年参与全国调查的1066例荷兰血友病患者至2018年7月,其中1031例(97%)有可用信息,142例(14%)死亡。与荷兰一般男性人群相比,血友病患者死亡率仍升高(标准化死亡比1.4,95%CI 1.2-1.7),中位预期寿命为77岁,较一般男性人群的83岁低6年。颅内出血和恶性肿瘤是最常见死因,过去45年血友病患者死亡率持续下降并趋近一般人群。

要点

  • 荷兰血友病患者死亡率仍高于一般男性人群,标准化死亡比1.4(95%CI 1.2-1.7)。
  • 中位预期寿命77岁,较一般男性人群的83岁低6年。
  • 颅内出血和恶性肿瘤是最常见死因,缺血性心脏病死亡持续较低。

核心结论

  • 荷兰血友病患者生存随时间改善,但仍低于一般人群。
  • 与一般男性人群相比死亡率仍升高,标准化死亡比1.4(95%CI 1.2-1.7)。
  • 中位预期寿命77岁,较一般男性人群的83岁低6年。

研究设计与样本

  • 观察性队列研究,随访2001年参与全国调查的全部1066例血友病患者至2018年7月。
  • 1031例(97%)有可用信息,142例(14%)在随访期间死亡。
  • 与1973年以来的既往生存评估进行比较。

主要发现

  • 颅内出血和恶性肿瘤是最常见死因。
  • 过去45年血友病患者死亡率持续下降,趋近一般人群生存体验。
  • 过去数十年HIV和HCV感染相关死亡减少,颅内出血死亡增加,缺血性心脏病死亡持续较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of patients with hemophilia has advanced over the past decades, but it is unknown whether this has resulted in a normal life expectancy in the Netherlands. OBJECTIVE: This observational cohort study aimed to assess all-cause and cause-specific mortality in patients with hemophilia in the Netherlands between 2001 and 2018 and to compare mortality and life expectancy with previous survival assessments from 1973 onward. PATIENTS/METHODS: All 1066 patients with hemophilia who participated in a nationwide survey in 2001 were followed until July 2018. RESULTS: Information on 1031 individuals (97%) was available, of whom 142 (14%) deceased during follow-up. Compared with the general Dutch male population, mortality of patients with hemophilia was still increased (standardized mortality ratio: 1.4, 95% confidence interval: 1.2-1.7). Intracranial bleeding and malignancies were the most common causes of death. Estimated median life expectancy of patients with hemophilia was 77 years, 6 years lower than the median life expectancy of the general Dutch male population (83 years). Over the past 45 years, death rates of patients with hemophilia have consistently decreased, approaching the survival experience of the general population. Over the past decades, mortality due to human immunodeficiency virus and hepatitis C virus infections has decreased, death due to intracranial hemorrhages has increased, and death due to ischemic heart disease has remained consistently low over time. CONCLUSIONS: Survival in patients with hemophilia in the Netherlands has improved over time but is still lower than that of the general population.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Hassan S, Monahan RC, Mauser-Bunschoten EP, et al. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018. J Thromb Haemost. 2020. PMID: 33217158. doi:10.1111/jth.15182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。